Truvestments Capital LLC Aptevo Therapeutics Inc. Transaction History

Truvestments Capital LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	BUY	$3.26 - $6.3 $309 - $598	95 New	95 $0
Q1 2022 May 02, 2022	SELL	$4.48 - $8.42 $425 - $799	-95 Closed	0 $0
Q3 2021 Oct 29, 2021	SELL	$15.01 - $22.16 $630 - $930	-42 Reduced 30.66%	95 $1,000
Q1 2021 May 18, 2021	BUY	$27.86 - $40.59 $3,816 - $5,560	137 New	137 $4,000

Ticker APVO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 5,090,640
Market Cap $22.4M
Description
Aptevo Therapeutics Inc., a clinical-stage biotechnology company, focuses on developing immunotherapeutic candidates for the treatment of various forms of cancer in the United States. Its lead clinical candidate is APVO436, a bispecific T-cell engaging antibody candidate that is in Phase 1b clinical trial for acute myelogenous leukemia and myelo...

Get notified when there are updates to the investment portfolio of Truvestments Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Truvestments Capital LLC with notifications on news.